Dendritic cell-endothelial cell cross-talk in angiogenesis

Trends in Immunology

Volumn 28, Issue 9, 2007, Pages 385-392

  Sozzani, Silvano ^a   Rusnati, Marco ^a   Riboldi, Elena ^a   Mitola, Stefania ^a   Presta, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIGEN PRESENTING CELL; CELL ACTIVATION; CELL ACTIVITY; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SUBPOPULATION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; HUMAN; IMMUNOREGULATION; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; REVIEW;

ANIMALS; CELL COMMUNICATION; DENDRITIC CELLS; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34548539834     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.07.006     Document Type: Review

References (89)

1. Choi K., et al. A common precursor for hematopoietic and endothelial cells. Development 125 (1998) 725-732
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
3. Rusnati M., and Presta M. Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. Endothelium 13 (2006) 93-111
4. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
5. Banchereau J., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
6. Steinman R.M. Some interfaces of dendritic cell biology. APMIS 111 (2003) 675-697
7. Sozzani S. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 16 (2005) 581-592
8. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
9. Colonna M., et al. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5 (2004) 1219-1226
10. Goerdt S., and Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10 (1999) 137-142
11. Mantovani A., et al. Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Novartis Found Symp. 256 (2004) 137-145 discussion 146-148, 259-269
12. Riboldi E., et al. Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J. Immunol. 175 (2005) 2788-2792
13. Guruli G., et al. Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. Blood 104 (2004) 2107-2115
14. Webster B., et al. Regulation of lymph node vascular growth by dendritic cells. J. Exp. Med. 203 (2006) 1903-1913
15. Fiallo P., et al. Overexpression of vascular endothelial growth factor and its endothelial cell receptor KDR in type 1 leprosy reaction. Am. J. Trop. Med. Hyg. 66 (2002) 180-185
16. Zhang M., et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat. Immunol. 5 (2004) 1124-1133
17. Strieter R.M., et al. Cancer CXC chemokine networks and tumour angiogenesis. Eur. J. Cancer 42 (2006) 768-778
18. Caux C., et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180 (1994) 1263-1272
19. Verhasselt V., et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 158 (1997) 2919-2925
20. de Graaf J.H., et al. The presence of cytokines in Langerhans' cell histiocytosis. J. Pathol. 180 (1996) 400-406
21. Konno S., et al. Interleukin-10 and Th2 cytokines differentially regulate osteopontin expression in human monocytes and dendritic cells. J. Interferon Cytokine Res. 26 (2006) 562-567
22. Naldini A., et al. Cutting edge: IL-1β mediates the proangiogenic activity of osteopontin-activated human monocytes. J. Immunol. 177 (2006) 4267-4270
23. Means T.K., et al. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J. Immunol. 170 (2003) 5165-5175
24. Vermi W., et al. Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. Blood 107 (2006) 454-462
25. Scimone M.L., et al. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology 114 (2005) 375-385
26. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
27. Stoll S., et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 28 (1998) 3231-3239
28. Piqueras B., et al. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107 (2006) 2613-2618
29. Doyen V., et al. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J. Exp. Med. 198 (2003) 1277-1283
30. Garlanda C., et al. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23 (2005) 337-366
31. Doni A., et al. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-γ. J. Leukoc. Biol. 79 (2006) 797-802
32. Doni A., et al. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur. J. Immunol. 33 (2003) 2886-2893
33. Asselin-Paturel C., and Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J. Exp. Med. 202 (2005) 461-465
34. Brassard D.L., et al. Interferon-α as an immunotherapeutic protein. J. Leukoc. Biol. 71 (2002) 565-581
35. Penna G., et al. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J. Immunol. 169 (2002) 6673-6676
36. Fonteneau J.F., et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78 (2004) 5223-5232
37. Curiel T.J., et al. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res. 64 (2004) 5535-5538
38. + T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer. J. Immunol. 177 (2006) 1460-1469
39. Rusnati M., et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 104 (2004) 92-99
40. Mantovani A., et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004) 677-686
41. Gabrilovich D.I., et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2 (1996) 1096-1103
42. Peichev M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
43. Barleon B., et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 (1996) 3336-3343
44. Mimura K., et al. Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2. Cancer Immunol. Immunother. 56 (2007) 761-770
45. Tordjman R., et al. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immunol. 3 (2002) 477-482
46. Chen L., et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat. Med. 10 (2004) 813-815
47. Dikov M.M., et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J. Immunol. 174 (2005) 215-222
48. Gabrilovich D.I., et al. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin. Cancer Res. 5 (1999) 2963-2970
49. Wulff C., et al. Angiogenesis during primate placentation in health and disease. Reproduction 126 (2003) 569-577
50. Juretic K., et al. An insight into the dendritic cells at the maternal-fetal interface. Am. J. Reprod. Immunol. 52 (2004) 350-355
51. Lee C.G., et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10 (2004) 1095-1103
52. Rutella S., et al. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108 (2006) 1435-1440
53. Li M.O., et al. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24 (2006) 99-146
54. low/neg accessory cells with dendritic-cell features. Blood 108 (2006) 218-227
55. Rusnati M., and Presta M. HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis 5 (2002) 141-151
56. Reinhart T.A. Chemokine induction by HIV-1: recruitment to the cause. Trends Immunol. 24 (2003) 351-353
57. Poggi A., et al. NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain. J. Immunol. 168 (2002) 95-101
58. Leali D., et al. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J. Immunol. 171 (2003) 1085-1093
59. Weiss J.M., et al. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194 (2001) 1219-1229
60. Renkl A.C., et al. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106 (2005) 946-955
61. Shinohara M.L., et al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7 (2006) 498-506
62. Marteau F., et al. Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106 (2005) 3860-3866
63. Demeure C.E., et al. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. 164 (2000) 2193-2199
64. Xia C.Q., and Kao K.J. Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells. Int. Immunol. 15 (2003) 1007-1015
65. Fricke I., et al. Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J. 18 (2004) 1588-1590
66. Harraz M., et al. CD34- blood-derived human endothelial cell progenitors. Stem Cells 19 (2001) 304-312
67. Fernandez Pujol B., et al. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur. J. Cell Biol. 80 (2001) 99-110
68. Choi J., et al. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22 (2004) 683-709
69. Conejo-Garcia J.R., et al. Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10 (2004) 950-958
70. + cell differentiation from a dendritic cell pathway into endothelial cells. Cancer Immunol. Immunother. 55 (2006) 558-568
71. Gottfried E., et al. Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis. Scand. J. Immunol. 65 (2007) 329-335
72. Conejo-Garcia J.R., et al. Vascular leukocytes contribute to tumor vascularization. Blood 105 (2005) 679-681
73. Coukos G., et al. The role of dendritic cell precursors in tumour vasculogenesis. Br. J. Cancer 92 (2005) 1182-1187
74. Bussolino F., et al. Semaphoring vascular morphogenesis. Endothelium 13 (2006) 81-91
75. Kumanogoh A., and Kikutani H. Immune semaphorins: a new area of semaphorin research. J. Cell Sci. 116 (2003) 3463-3470
76. Kumanogoh A., et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419 (2002) 629-633
77. Walzer T., et al. Plexin C1 engagement on mouse dendritic cells by viral semaphorin A39R induces actin cytoskeleton rearrangement and inhibits integrin-mediated adhesion and chemokine-induced migration. J. Immunol. 174 (2005) 51-59
78. Wong A.W., et al. CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. Nat. Immunol. 4 (2003) 891-898
79. Conrotto P., et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105 (2005) 4321-4329
80. Svensson M., and Kaye P.M. Stromal-cell regulation of dendritic-cell differentiation and function. Trends Immunol. 27 (2006) 580-587
81. Randolph G.J., et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282 (1998) 480-483
82. + peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells. J. Immunol. 160 (1998) 2675-2683
83. Tang H., et al. Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10. Blood 108 (2006) 1189-1197
84. Moldenhauer A., et al. Tumor necrosis factor α-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells. Stem Cells 22 (2004) 144-157
85. Despars G., et al. Molecular definition of an in vitro niche for dendritic cell development. Exp. Hematol. 32 (2004) 1182-1193
86. Vulcano M., et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 31 (2001) 812-822
87. de Saint-Vis B., et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160 (1998) 1666-1676
88. Cella M., et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184 (1996) 747-752
89. Boonstra A., et al. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177 (2006) 7551-7558